- by sedlv
- January 11 2022
(Jan 11, 2022)
California-based Dren Bio and Pfizer have partnered on a deal valued at more than $1 billion to discover and develop therapeutic bispecific antibodies for select oncology targets.
$1 BILLION PFIZER-DREN BIO DEAL HIGHLIGHTS ANOTHER DAY OF COLLABORATIONS